Ramakrishnan, G <br/><br/>
Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells.  [electronic resource] 

 -  Cell proliferation  Apr 2009 
 - 229-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2184 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2184.2008.00581.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Apoptotic Protease-Activating Factor 1--metabolism<br/>Caspase 3--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Nucleus--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin D1--metabolism<br/>Cytochromes c--metabolism<br/>DNA Fragmentation--drug effects<br/>Dose-Response Relationship, Drug<br/>Flavonoids--pharmacology<br/>Gene Expression--drug effects<br/>Humans<br/>Inhibitor of Apoptosis Proteins<br/>Liver Neoplasms--drug therapy<br/>Membrane Potential, Mitochondrial--drug effects<br/>Microtubule-Associated Proteins--metabolism<br/>Mitochondria--drug effects<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Silymarin--pharmacology<br/>Survivin<br/>Tumor Suppressor Protein p53--metabolism<br/>bcl-2-Associated X Protein--metabolism<br/>beta Catenin--metabolism